Related references
Note: Only part of the references are listed.Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy
D. Hernan Perez de la Ossa et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Roger G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Angelo A. Izzo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
JunD is involved in the antiproliferative effect of Δ9-tetrahydrocannabinol on human breast cancer cells
M. M. Caffarel et al.
ONCOGENE (2008)
Cannabinoids as potential new therapy for the treatment of gliomas
Daniela Parolaro et al.
Expert Review of Neurotherapeutics (2007)
Formulation of spray-dried phenytoin loaded poly(ε-caprolactone) microcarrier intended for brain delivery to treat epilepsy
Zhuzhu Li et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Precipitation complexation method produces cannabidiol/β-cyclodextrin inclusion complex suitable for sublingual administration of cannabidiol.
Janne Mannila et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Cannabidiol - Recent advances
Raphael Mechoulam et al.
CHEMISTRY & BIODIVERSITY (2007)
Structure elucidation of the tetrahydrocannabinol complex with randomly methylated β-cyclodextrin
Arno Hazekamp et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
Alessia Ligresti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Cannabinoids in medicine: A review of their therapeutic potential
MB Amar
JOURNAL OF ETHNOPHARMACOLOGY (2006)
In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(ε-caprolactone) micelles
ML Forrest et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Temperature stability and bioadhesive properties of Delta(9)-tetrahydrocannabinol incorporated hydroxypropylcellulose polymer matrix systems
MA Repka et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2006)
Chemical stabilization of a Delta 9-tetrahydrocannabinol prodrug in polymeric matrix systems produced by a hot-melt method: Role of microenvironment pH
Manish Munjal et al.
AAPS PHARMSCITECH (2006)
Spray freeze drying to produce a stable Δ9-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation
DJ van Drooge et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Cannabinoids and cancer: potential for colorectal cancer therapy
HA Patsos et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
Biodegradable additives modulate ganciclovir release rate from PLGA microspheres destined to intraocular administration
E Barcia et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2005)
Poly-ε-caprolactone microspheres and nanospheres:: an overview
VR Sinha et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Possible endocannabinoid control of colorectal cancer growth
A Ligresti et al.
GASTROENTEROLOGY (2003)
A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®):: PLGA nanoparticles containing vitamin E TPGS
L Mu et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Pharmacokinetics and pharmacodynamics of cannabinoids
F Grotenhermen
CLINICAL PHARMACOKINETICS (2003)
Oral morphine and respiratory function amongst hospice inpatients with advanced cancer
TD Walsh et al.
SUPPORTIVE CARE IN CANCER (2003)
Physiochemical and pharmacological characterization of a Δ9-THC aerosol generated by a metered dose inhaler
DM Wilson et al.
DRUG AND ALCOHOL DEPENDENCE (2002)
Modeling and comparison of dissolution profiles
P Costa et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Share Paper
